查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1599299

全球病毒学检体采集市场：按产品、检体和最终用户分类 - 预测 2025-2030 年

Virology Specimen Collection Market by Product (Blood Collection Kits, Specimen Collection Tubes, Swabs), Sample (Blood Samples, Cervical Samples, Nasal Samples), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年病毒学检体体采集市场​​价值为26.8亿美元，预计到2024年将达到33.1亿美元，复合年增长率为23.89%，预计到2030年将达到120.5亿美元。

病毒学检体体采集市场​​的定义是其在采集诊断病毒感染所需样本（例如拭子、血液、尿液和唾液）方面的作用。这个市场需要准确的诊断工具来应对大流行的准备和常规病毒学。其应用范围从临床诊断和药物发现到流行病学研究，影响医院、诊断实验室和研究机构。该领域的驱动因素包括病毒爆发的增加、对感染疾病的认识提高以及收集方法的进步。自动化、人工智慧以及储存和运输技术的改进代表了重大商机。透过利用这些进步，公司可以期待强劲的成长。建议重点关注提高样品完整性和整合数位诊断平台。儘管存在成长机会，但市场成长面临挑战，例如高成本、严格的法律规范以及与运输和储存检体相关的物流复杂性。为了克服这些问题，企业应优先考虑旨在简化供应链的具有成本效益的创新和伙伴关係。

主要市场统计
基准年[2023] 26.8亿美元
预测年份 [2024] 33.1亿美元
预测年份 [2030] 120.5亿美元
复合年增长率（%） 23.89%

新的商机在于开发提供便利性和可靠性的快速检体采集套件，特别是在资源有限的环境中。投资可携式诊断设备，最大限度地减少对复杂基础设施的需求，也可以使市场参与者脱颖而出。将检体采集与综合诊断服务联繫起来的远端医疗和数位健康解决方案的作用也是一个有前途的发展途径。技术创新必须着重于提高检体分析的便携性、准确性和速度。市场竞争激烈且快速发展，需要不断适应新技术和客户需求。透过专注于能够快速应对突发卫生事件的可扩展解决方案，公司可以巩固其在全球病毒学领域的作用。这种策略创新和合作关係使企业不仅能够满足当前的需求，还能有效应对未来不可预见的挑战。

市场动态：快速发展的病毒学检体采集市场的关键市场洞察

供需的动态交互作用正在改变病毒学检体体采集市场​​。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 病毒性疾病的流行和新病原体的出现
    • 捐血增加
    • 政府为维护检体采集安全而製定的准则
  • 市场限制因素
    • 对检体采集、处理和运输程序不完善的担忧
  • 市场机会
    • 来自公共和私人机构的强大财政支持
    • 抗病毒疗法的开发进展
  • 市场挑战
    • 病毒学检体采集技术高成本检体

波特检体力：驾驭病毒学检体采集市场​​的策略工具

波特的五力架构是了解病毒学检体体采集市场​​竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解病毒学检体采集市场​​的外部影响

外部宏观环境因素在塑造病毒学检体体采集市场​​的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解病毒学检体采集市场​​的竞争格局

对病毒学检体采集市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵病毒学检体采集市场供应商的绩效评估

FPNV定位矩阵是评估病毒学检体体采集市场​​供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划病毒学检体采集市场​​的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对病毒学检体采集市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 病毒性疾病的传播和新病原体的出现
      • 捐血增加
      • 政府制定指导方针以确保检体采集安全
    • 抑制因素
      • 对收集、处理和运输程序不完善的担忧
    • 机会
      • 来自公私机构的雄厚资金
      • 抗病毒疗法的发展进展
    • 任务
      • 病毒学检体检体技术高成本
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章病毒学检体采集市场​​：副产品

  • 血液采集套件
  • 检体采集管
  • 棉花棒
  • 病毒运输媒介

第七章 病毒学检体体采集市场​​样本

  • 血液样本
  • 子宫颈样本
  • 鼻腔样本
  • 鼻咽样本
  • 口腔样本
  • 喉咙样本

第八章病毒学检体采集市场​​：依最终使用者分类

  • 诊断中心
  • 医院/诊所

第九章美洲病毒学检体采集市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区病毒学检检体采集市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲病毒学检检体采集市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Element Materials Technology Group Limited
  • Hardy Diagnostics
  • HiMedia Laboratories, LLC
  • LABORATORY ALLIANCE OF CENTRAL NEW YORK, LLC
  • Laboratory Corporation of America Holdings
  • Medical Wire & Equipment
  • Merck KGaA
  • Omega Bio-tek, Inc.
  • PHARMIWEB.COM LIMITED
  • Puritan Medical Products
  • Quidel Corporation
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech PLC
Product Code: MRR-8201ABF20F0B

The Virology Specimen Collection Market was valued at USD 2.68 billion in 2023, expected to reach USD 3.31 billion in 2024, and is projected to grow at a CAGR of 23.89%, to USD 12.05 billion by 2030.

The market for virology specimen collection is defined by its role in acquiring samples necessary for diagnosing viral infections, which include swabs, blood, urine, and saliva. This market is indispensable due to the critical need for accurate diagnostic tools in both pandemic preparedness and routine virology. Its applications range from clinical diagnostics and drug discovery to epidemiological research, impacting hospitals, diagnostic labs, and research institutes. Driving factors in this sector include the rise in viral outbreaks, heightened awareness about infectious diseases, and advancements in collection methodologies. The use of automation, AI, and improved storage and transport technologies presents significant opportunities. For businesses, tapping into these advancements can yield robust growth; a focus on enhancing sample integrity and integrating digital diagnostic platforms is advised. Despite opportunities, market growth faces challenges such as high costs, stringent regulatory frameworks, and logistical complexities associated with specimen transport and storage. To overcome these, businesses should prioritize cost-effective innovations and partnerships aimed at enhancing supply chain efficiency.

KEY MARKET STATISTICS
Base Year [2023] USD 2.68 billion
Estimated Year [2024] USD 3.31 billion
Forecast Year [2030] USD 12.05 billion
CAGR (%) 23.89%

Emerging opportunities lie in developing rapid specimen collection kits that offer convenience and reliability, particularly in resource-constrained settings. Investing in portable diagnostic devices that minimize the need for complex infrastructure can also differentiate market players. The role of telemedicine and digital health solutions in linking specimen collection with comprehensive diagnostic services is another promising avenue for development. Innovation must focus on improving portability, accuracy, and speed of specimen analysis. The market is competitive and rapidly evolving, necessitating constant adaptation to new technologies and customer needs. Companies will benefit from focusing on scalable solutions that can swiftly respond to health emergencies, thus solidifying their role in the global virology landscape. These strategic innovations and collaborations will position businesses to not only meet current demands but also address unforeseen future challenges effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Virology Specimen Collection Market

The Virology Specimen Collection Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of viral diseases and emergence of newer pathogens
    • Growing number of blood donations
    • Government set guidelines to maintain safety of specimen collection
  • Market Restraints
    • Concerns regarding inadequate procedures for collection, handling, transport
  • Market Opportunities
    • Robust funding from the public and private agencies
    • Development progress in antiviral therapeutics
  • Market Challenges
    • High cost of virology specimen collection technologies

Porter's Five Forces: A Strategic Tool for Navigating the Virology Specimen Collection Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Virology Specimen Collection Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Virology Specimen Collection Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Virology Specimen Collection Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Virology Specimen Collection Market

A detailed market share analysis in the Virology Specimen Collection Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Virology Specimen Collection Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Virology Specimen Collection Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Virology Specimen Collection Market

A strategic analysis of the Virology Specimen Collection Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Virology Specimen Collection Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Becton, Dickinson and Company, Element Materials Technology Group Limited, Hardy Diagnostics, HiMedia Laboratories, LLC, LABORATORY ALLIANCE OF CENTRAL NEW YORK, LLC, Laboratory Corporation of America Holdings, Medical Wire & Equipment, Merck KGaA, Omega Bio-tek, Inc., PHARMIWEB.COM LIMITED, Puritan Medical Products, Quidel Corporation, Thermo Fisher Scientific Inc., and Trinity Biotech PLC.

Market Segmentation & Coverage

This research report categorizes the Virology Specimen Collection Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Blood Collection Kits, Specimen Collection Tubes, Swabs, and Viral Transport Media.
  • Based on Sample, market is studied across Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Oral Samples, and Throat Samples.
  • Based on End User, market is studied across Diagnostic Centers and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of viral diseases and emergence of newer pathogens
      • 5.1.1.2. Growing number of blood donations
      • 5.1.1.3. Government set guidelines to maintain safety of specimen collection
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns regarding inadequate procedures for collection, handling, transport
    • 5.1.3. Opportunities
      • 5.1.3.1. Robust funding from the public and private agencies
      • 5.1.3.2. Development progress in antiviral therapeutics
    • 5.1.4. Challenges
      • 5.1.4.1. High cost of virology specimen collection technologies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Virology Specimen Collection Market, by Product

  • 6.1. Introduction
  • 6.2. Blood Collection Kits
  • 6.3. Specimen Collection Tubes
  • 6.4. Swabs
  • 6.5. Viral Transport Media

7. Virology Specimen Collection Market, by Sample

  • 7.1. Introduction
  • 7.2. Blood Samples
  • 7.3. Cervical Samples
  • 7.4. Nasal Samples
  • 7.5. Nasopharyngeal Samples
  • 7.6. Oral Samples
  • 7.7. Throat Samples

8. Virology Specimen Collection Market, by End User

  • 8.1. Introduction
  • 8.2. Diagnostic Centers
  • 8.3. Hospitals & Clinics

9. Americas Virology Specimen Collection Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Virology Specimen Collection Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Virology Specimen Collection Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Becton, Dickinson and Company
  • 3. Element Materials Technology Group Limited
  • 4. Hardy Diagnostics
  • 5. HiMedia Laboratories, LLC
  • 6. LABORATORY ALLIANCE OF CENTRAL NEW YORK, LLC
  • 7. Laboratory Corporation of America Holdings
  • 8. Medical Wire & Equipment
  • 9. Merck KGaA
  • 10. Omega Bio-tek, Inc.
  • 11. PHARMIWEB.COM LIMITED
  • 12. Puritan Medical Products
  • 13. Quidel Corporation
  • 14. Thermo Fisher Scientific Inc.
  • 15. Trinity Biotech PLC

LIST OF FIGURES

  • FIGURE 1. VIROLOGY SPECIMEN COLLECTION MARKET RESEARCH PROCESS
  • FIGURE 2. VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. VIROLOGY SPECIMEN COLLECTION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. VIROLOGY SPECIMEN COLLECTION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VIROLOGY SPECIMEN COLLECTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VIROLOGY SPECIMEN COLLECTION MARKET DYNAMICS
  • TABLE 7. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD COLLECTION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN COLLECTION TUBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY VIRAL TRANSPORT MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CERVICAL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASAL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASOPHARYNGEAL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ORAL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THROAT SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. VIROLOGY SPECIMEN COLLECTION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. VIROLOGY SPECIMEN COLLECTION MARKET, FPNV POSITIONING MATRIX, 2023